Beta Blockers: Less Effect on Pulse Pressure Than DiureticsCMEA new review of the use of beta blockers as second-line therapy for primary hypertension has shown that they appear to lower BP in a different way than thiazide diuretics, with less of an effect on pulse pressure.
Heartwire CME, February 2010
Breaking Down the Walls in Atrial Fibrillation TherapyCMEAtrial fibrillation affects nearly 7 million people in the United States and Europe. Please join Drs. Breithardt, Connolly, Crijns, Kirchhof, and Naccarelli for a discussion on strategies to improve outcomes in patients with AF.
Diagnostic Imaging and Biomarkers in Cardiology CME
Precursors of Cardiovascular Disease and Emerging Strategies With StatinsCMEDyslipidemia is only one signal of cardiovascular disease (CVD) risk. Inflammation is a frequent precursor of cardiac-related events. Drs. Willerson, Ballantyne, and Ridker critically examine the mechanisms of atherosclerosis, elevated C-reactive protein and other risk factors, and statin therapy to preemptively address or ameliorate CVD.
February 2010
CT More Accurate Than MRI for Ruling out Coronary Artery DiseaseCMEResults from a new meta-analysis showed that CT has better sensitivity and specificity than MRI, leading researchers to conclude that it is more advantageous for detecting and ruling out clinically relevant coronary stenoses.
VTACH: Ablation Before ICD Reduces Recurrence of Ventricular TachycardiaCMECatheter ablation before the implantation of a defibrillator prolongs the time to recurrence of VT in patients with prior MI and reduced left ventricular ejection fraction, according to the VTACH investigators. The results are in line with the benefit observed in SMASH-VT.
Beta Blockers: Less Effect on Pulse Pressure Than DiureticsCMEA new review of the use of beta blockers as second-line therapy for primary hypertension has shown that they appear to lower BP in a different way than thiazide diuretics, with less of an effect on pulse pressure.
Heartwire CME, February 2010
Weight Loss Important in BP Management: ENCORE PublishedCMEThe ENCORE study, illustrating how weight management augments the blood-pressure-lowering effects of the Dietary Approaches to Stop Hypertension (DASH) diet, has been published.
Precursors of Cardiovascular Disease and Emerging Strategies With StatinsCMEDyslipidemia is only one signal of cardiovascular disease (CVD) risk. Inflammation is a frequent precursor of cardiac-related events. Drs. Willerson, Ballantyne, and Ridker critically examine the mechanisms of atherosclerosis, elevated C-reactive protein and other risk factors, and statin therapy to preemptively address or ameliorate CVD.
February 2010
Same Weight Loss, Better BP With Low-Carb Diet vs Drug/Diet Combo CMEThe one-year randomized study is the first to compare the low-carb diet with a low-fat strategy in combination with a diet drug. While lipid changes were similar, diastolic and systolic BP improved more with low-carb.
Precursors of Cardiovascular Disease and Emerging Strategies With StatinsCMEDyslipidemia is only one signal of cardiovascular disease (CVD) risk. Inflammation is a frequent precursor of cardiac-related events. Drs. Willerson, Ballantyne, and Ridker critically examine the mechanisms of atherosclerosis, elevated C-reactive protein and other risk factors, and statin therapy to preemptively address or ameliorate CVD.
Stent Thrombosis: A Case-Based DiscussionCMEDr. Holmvang presents 2 cases of stent thrombosis to Dr. Kristensen outlining risk factors and potential strategies to prevent this catastrophic event.
The Genetics of Antiplatelet Responsiveness CMECarriers of certain CYP genetic variants have lower levels of clopidogrel's active metabolite and experience higher rates of MACE. What role should genotyping play in optimizing antiplatelet therapy? Dr. Simon discusses recent data on these topics with Dr. Mega.